Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
Globus Medical (NYSE: GMED) will participate in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, from October 23-26, 2024. The company will showcase its orthopedic trauma product portfolio at booth #361, featuring recent additions such as TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments, and CAPTIVATE™ SOLA Headless Screws.
Globus will also present the PRECICE™ Ankle Salvage System, designed to compress the tibia-talar-calcaneus joint and offer limb lengthening options. The company will host a workshop on internal limb reconstruction for complex cases on October 24. This marks the second year Globus Medical is presenting PRECICE™ as part of its broader orthopedic trauma portfolio, which includes FDA-cleared technologies for limb lengthening and bone transport in long bones.
Globus Medical (NYSE: GMED) parteciperà al 40° Congresso Annuale dell'Orthopedic Trauma Association (OTA) a Montréal, Canada, dal 23 al 26 ottobre 2024. L'azienda presenterà il suo portafoglio di prodotti per il trauma ortopedico allo stand #361, mettendo in mostra recenti aggiunte come il TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments e CAPTIVATE™ SOLA Headless Screws.
Globus presenterà anche il PRECICE™ Ankle Salvage System, progettato per comprimere l'articolazione tibia-talar-calcagno e offrire opzioni di allungamento degli arti. L'azienda ospiterà un workshop sulla ricostruzione interna degli arti per casi complessi il 24 ottobre. Questo segna il secondo anno in cui Globus Medical presenta il PRECICE™ come parte del suo portafoglio più ampio di trauma ortopedico, che include tecnologie approvate dalla FDA per l'allungamento dell'arto e il trasporto dell'osso negli arti lunghi.
Globus Medical (NYSE: GMED) participará en la 40ª Reunión Anual de la Orthopedic Trauma Association (OTA) en Montreal, Canadá, del 23 al 26 de octubre de 2024. La empresa exhibirá su cartera de productos para el trauma ortopédico en el stand #361, presentando adiciones recientes como el TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments y CAPTIVATE™ SOLA Headless Screws.
Globus también presentará el PRECICE™ Ankle Salvage System, diseñado para comprimir la articulación tibia-talar-calcáneo y ofrecer opciones de alargamiento de extremidades. La empresa organizará un taller sobre reconstrucción interna de extremidades para casos complejos el 24 de octubre. Este es el segundo año que Globus Medical presenta el PRECICE™ como parte de su cartera más amplia de trauma ortopédico, que incluye tecnologías aprobadas por la FDA para el alargamiento de extremidades y el transporte de huesos en huesos largos.
글로부스 메디컬(뉴욕증권거래소: GMED)은 2024년 10월 23일부터 26일까지 캐나다 몬트리올에서 열리는 제40회 정형외과 외상 학회(Orthopedic Trauma Association (OTA))에 참가합니다. 회사는 #361 부스에서 정형외과 외상 제품 포트폴리오를 선보이며, 최근 추가된 TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments 및 CAPTIVATE™ SOLA Headless Screws를 포함할 것입니다.
글로부스는 또한 PRECICE™ Ankle Salvage System을 발표하며, 이는 경골-탈구-발꿈치 관절을 압축하여 사지 길이 연장 옵션을 제공합니다. 이 회사는 10월 24일 복잡한 사례를 위한 내부 사지 재건 워크숍을 개최할 예정입니다. 이는 글로부스 메디컬이 PRECICE™를 보다 광범위한 정형외과 외상 포트폴리오의 일환으로 발표하는 두 번째 해입니다. 이 포트폴리오는 사지 길이 연장 및 긴 뼈의 뼈 이동을 위한 FDA 승인 기술을 포함합니다.
Globus Medical (NYSE: GMED) participera à la 40e Réunion Annuelle de l'Orthopedic Trauma Association (OTA) à Montréal, Canada, du 23 au 26 octobre 2024. L'entreprise présentera son portefeuille de produits pour le traumatisme orthopédique au stand #361, mettant en avant des ajouts récents tels que le TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments et CAPTIVATE™ SOLA Headless Screws.
Globus présentera également le PRECICE™ Ankle Salvage System, conçu pour comprimer l'articulation tibia-talar-calcaneus et offrir des options d'allongement des membres. L'entreprise organisera un atelier sur la reconstruction interne des membres pour des cas complexes le 24 octobre. C'est la deuxième année que Globus Medical présente le PRECICE™ dans le cadre de son portefeuille plus large de traumatologie orthopédique, qui comprend des technologies approuvées par la FDA pour l'allongement des membres et le transport osseux dans les os longs.
Globus Medical (NYSE: GMED) wird an der 40. Jahreshauptversammlung der Orthopedic Trauma Association (OTA) in Montreal, Kanada, vom 23. bis 26. Oktober 2024 teilnehmen. Das Unternehmen wird sein Portfolio an orthopädischen Trauma-Produkten am Stand #361 präsentieren, darunter Neuheiten wie TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments und CAPTIVATE™ SOLA Headless Screws.
Globus wird auch das PRECICE™ Ankle Salvage System vorstellen, das entwickelt wurde, um das Tibia-Talar-Kalkaneus-Gelenk zu komprimieren und Optionen zur Beinlängenveränderung anzubieten. Das Unternehmen wird am 24. Oktober einen Workshop zur inneren Rekonstruktion von Gliedmaßen für komplexe Fälle veranstalten. Dies ist das zweite Jahr, in dem Globus Medical PRECICE™ als Teil seines umfassenderen Portfolios für orthopädisches Trauma präsentiert, das FDA-zugelassene Technologien für die Verlängerung von Gliedmaßen und den Knochenumschlag in langen Knochen umfasst.
- None.
- None.
AUDUBON, Pa., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, is participating in the 40th Annual Meeting of the Orthopedic Trauma Association (OTA) in Montréal, Canada, October 23—26.
Join Globus at booth #361 during OTA for product demonstrations of the PRECICE™ technologies and our full orthopedic trauma product portfolio. Special highlights include our most recent additions to the portfolio including TENSOR™ Suture Button, ANTHEM™ II Distal Radius Volar Plates, AUTOBAHN™ Trochanteric Nail PRO Instruments, and CAPTIVATE™ SOLA Headless Screws.
Globus Medical will also showcase the most recent addition to the PRECICE™ Platform – the PRECICE™ Ankle Salvage System, the only nail on the market that is designed to compress the tibia-talar-calcaneus (TTC) joint intraoperatively and postoperatively, while also giving an option to lengthen the limb post-fusion.
“We are excited to offer our customers technology that is designed to make surgery easier for surgeons and provide better care for patients,” commented John Mulcahy, president of Orthopedics and chief commercial officer at Globus Medical. “For example, the PRECICE™ Nailing System and the ANTHEM™ Plating System can provide unique solutions to our trauma surgeons for large traumatic bone defects via the Plate Assisted Bone Segment Transport technique.”
Globus welcomes OTA attendees to join our workshop where an esteemed faculty will present all-internal limb reconstruction options for complex cases.
Thursday, October 24, 2024: 12:00 – 1:00pm
Internal Limb Reconstruction for Extremely Challenging Cases
- Moderator: Stephen Quinnan, MD – Paley Orthopedic & Spine Institute, West Palm Beach, FL
- Geoffrey Marecek, MD – Cedars-Sinai Medical Center, Los Angeles, CA
- Paul Matuszewski, MD – University of Kentucky Hospital, Lexington, KY
- John Scolaro, MD – University of California Irvine, Orange, CA
This will be the second year Globus Medical is presenting PRECICETM as part of the broader orthopedic trauma portfolio. With many clinical studies, the all-internal limb lengthening technology continues to help revolutionize limb reconstruction in the trauma market. The PRECICETM Intramedullary Limb Lengthening System is FDA cleared for limb lengthening, open and closed fracture fixation, pseudarthrosis, malunions, nonunions, or bone transport of long bones in patients aged 18 years and older and indicated for limb lengthening of the femur and tibia in pediatric patients (greater than 12 years old). This system, along with ANTHEM™ Plating systems, can provide solution for bone transport in long bones.
Learn more about our events at OTA: https://www.globusmedical.com/events/conferences/ota-2023/
Learn more about the Orthopedic Trauma Portfolio: https://www.globusmedical.com/musculoskeletal-solutions/trauma/
About Globus Medical, Inc.
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives. We innovate with inspired urgency, provide world-class education and clinical support, and advance care throughout spine, orthopedic trauma, joint reconstruction, biomaterials and enabling technologies. Additional information can be accessed at https://www.globusmedical.com/.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, the risks and costs associated with the integration of, and the ability of Globus Medical and NuVasive to integrate, their businesses successfully and to achieve anticipated synergies, health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Investor contact:
Brian Kearns
610-930-1800
investors@globusmedical.com
Media contact:
Moran Chavez
media@globusmedical.com
FAQ
When and where is Globus Medical participating in the Orthopedic Trauma Association Annual Meeting?
What new products will Globus Medical (GMED) showcase at the OTA 2024 meeting?
What is the PRECICE™ Ankle Salvage System presented by Globus Medical (GMED) at OTA 2024?
When is Globus Medical (GMED) hosting a workshop at the OTA 2024 meeting?
What are the FDA clearances for Globus Medical's (GMED) PRECICE™ Intramedullary Limb Lengthening System?
